Insider · CIK 0002030874

Tennant Phil

Reports to the SEC for 1 company · GERMANTOWN, MD

sec.gov

Transactions

Companies

Filings

CIK

0002030874

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-25	PGENPRECIGEN, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+79.2K sh	$1.61	+$127K	221,158
2026-08-25	PGENPRECIGEN, INC.S Sale	Chief Commercial Officer	SSale	−79.2K sh	$7.50	−$594K	141,992
2026-08-25	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−79.2K sh	—	—	120,834
2026-08-23	PGENPRECIGEN, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+5,208 sh	—	—	144,577
2026-08-23	PGENPRECIGEN, INC.F Tax Payment	Chief Commercial Officer	FTax Payment	−2,585 sh	$7.20	−$18.6K	141,992
2026-08-23	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−5,208 sh	—	—	57,292
2026-05-28	PGENPRECIGEN, INC.S Sale	Chief Commercial Officer	SSale	−30.3K sh	$4.36	−$132K	139,369
2026-05-23	PGENPRECIGEN, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+62.5K sh	—	—	169,641
2026-05-23	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−62.5K sh	—	—	62,500
2026-04-20	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	Chief Commercial Officer	AAward	+385K sh	—	—	385,000
2026-04-20	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+115K sh	—	—	115,000
2026-03-18	PGENPRECIGEN, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+42.1K sh	—	—	107,141
2026-03-18	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+42.1K sh	—	—	42,110
2026-03-18	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−42.1K sh	—	—	0
2025-09-29	PGENPRECIGEN, INC.P Purchase	Chief Commercial Officer	PPurchase	+6,000 sh	$3.58	+$21.5K	65,031
2025-09-12	PGENPRECIGEN, INC. · Performance Stock UnitsA Award	Chief Commercial Officer	AAward	+25K sh	—	—	25,000
2025-06-26	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+125K sh	—	—	125,000
2025-05-23	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	Chief Commercial Officer	AAward	+250K sh	—	—	250,000
2025-05-16	PGENPRECIGEN, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+66.4K sh	—	—	82,000
2025-05-16	PGENPRECIGEN, INC.F Tax Payment	Chief Commercial Officer	FTax Payment	−23K sh	$1.45	−$33.3K	59,031
2025-05-16	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−66.4K sh	—	—	0
2025-04-17	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+66.4K sh	—	—	66,441
2025-01-29	PGENPRECIGEN, INC.A Award	Chief Commercial Officer	AAward	+25K sh	—	—	25,000
2025-01-29	PGENPRECIGEN, INC.F Tax Payment	Chief Commercial Officer	FTax Payment	−9,441 sh	$1.30	−$12.3K	15,559
2024-07-22	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	Chief Commercial Officer	AAward	+200K sh	—	—	200,000

Recent filings

Accepted (ET)
Aug 254
Tennant Phil0000950103-26-012871
SEC(opens sec.gov)
Jun 14
Tennant Phil0000950103-26-008172
SEC(opens sec.gov)
May 274
Tennant Phil0000950103-26-007844
SEC(opens sec.gov)
Apr 224
Tennant Phil0000950103-26-006042
SEC(opens sec.gov)
Mar 204
Tennant Phil0000950103-26-004490
SEC(opens sec.gov)
Sep 304
Tennant Phil0000950103-25-012557
SEC(opens sec.gov)
Sep 164
Tennant Phil0000950103-25-011723
SEC(opens sec.gov)
Jun 274
Tennant Phil0000950103-25-007995
SEC(opens sec.gov)
May 274
Tennant Phil0000950103-25-006451
SEC(opens sec.gov)
May 164
Tennant Phil0000950103-25-006147
SEC(opens sec.gov)

Companies

PRECIGEN, INC.Chief Commercial OfficerPGEN

Address

20374 SENECA MEADOWS PARKWAY

GERMANTOWN, MD, 20876